HomeComparePODD vs HRC

PODD vs HRC: Dividend Comparison 2026

PODD yields 0.96% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRC wins by $2.24M in total portfolio value
10 years
PODD
PODD
● Live price
0.96%
Share price
$208.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.0K
Annual income
$102.34
Full PODD calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — PODD vs HRC

📍 HRC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPODDHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PODD + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PODD pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PODD
Annual income on $10K today (after 15% tax)
$81.73/yr
After 10yr DRIP, annual income (after tax)
$86.99/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, HRC beats the other by $1,209,828.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PODD + HRC for your $10,000?

PODD: 50%HRC: 50%
100% HRC50/50100% PODD
Portfolio after 10yr
$1.14M
Annual income
$711,765.99/yr
Blended yield
62.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PODD right now

PODD
Analyst Ratings
36
Buy
10
Hold
3
Sell
Consensus: Buy
Price Target
$357.25
+71.7% upside vs current
Range: $286.00 — $435.00
Altman Z
7.1
Piotroski
7/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PODD buys
0
HRC buys
0
No recent congressional trades found for PODD or HRC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPODDHRC
Forward yield0.96%11.38%
Annual dividend / share$2.00$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.3%
Portfolio after 10y$21.0K$2.26M
Annual income after 10y$102.34$1,423,429.65
Total dividends collected$995.00$2.14M
Payment frequencyquarterlyquarterly
SectorStockStock
Analyst consensusBuyHold

Year-by-year: PODD vs HRC ($10,000, DRIP)

YearPODD PortfolioPODD Income/yrHRC PortfolioHRC Income/yrGap
1← crossover$10,796$96.15$12,296$1,595.93$1.5KHRC
2$11,649$97.01$15,730$2,573.05$4.1KHRC
3$12,562$97.83$21,147$4,316.00$8.6KHRC
4$13,540$98.60$30,235$7,608.15$16.7KHRC
5$14,587$99.32$46,615$14,263.36$32.0KHRC
6$15,708$100.00$78,712$28,834.27$63.0KHRC
7$16,909$100.64$148,063$63,841.01$131.2KHRC
8$18,193$101.24$315,890$157,462.80$297.7KHRC
9$19,569$101.81$778,498$440,495.17$758.9KHRC
10$21,041$102.34$2,256,422$1,423,429.65$2.24MHRC

PODD vs HRC: Complete Analysis 2026

PODDStock

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Full PODD Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this PODD vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PODD vs SCHDPODD vs JEPIPODD vs OPODD vs KOPODD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.